A strep positive in pregnancy means a woman tests positive for group B streptococcus (GBS), a bacterium that can be present in the vagina or rectum without symptoms. This result triggers preventive measures during labor to protect the newborn from infection.
GBS is common-about 25% of pregnant people carry it asymptomatically. The bacteria can colonize the lower genital tract and be passed to the baby during vaginal delivery. Without intervention, about 1 in 200 exposed infants develop early-onset GBS disease, which can cause sepsis, pneumonia, or meningitis.
Screening occurs between 35 and 37 weeks gestation. A swab from the vagina and rectum is sent to a lab. Results are reported as positive or negative. A positive result means the person is a carrier, not that they have an active infection. Carriage status can change between screenings, so timing matters.
Healthcare providers use a standardized protocol. A sterile swab is inserted into the lower vagina and then into the rectum. The swab is placed in transport medium and sent to a microbiology lab. Culture-based testing takes 24-48 hours and remains the gold standard.
Some clinics use nucleic acid amplification tests (NAATs), which detect bacterial DNA faster. NAATs have higher sensitivity-up to 98% compared to 85% for culture-but are not universally available. The CDC recommends culture-based testing due to better validation in large populations.
Testing at 36 weeks is critical. GBS carriage can fluctuate. A test done earlier may miss colonization that develops later. The American College of Obstetricians and Gynecologists (ACOG) states that screening should occur no earlier than 35 weeks and no later than 37 weeks.
Not all deliveries pose equal risk. Factors influencing transmission include:
When any of these conditions exist, the risk of transmission increases even if the mother is GBS-negative. For GBS-positive mothers, intravenous antibiotics during labor reduce the risk of neonatal infection by 80%.
| Risk Factor | Impact on Transmission Risk | Recommended Action |
|---|---|---|
| GBS positive, no risk factors | Low | Antibiotics during labor |
| GBS positive, membranes ruptured >18 hours | High | Antibiotics during labor |
| GBS unknown, fever during labour | Medium-high | Antibiotics during labour |
| GBS negative, previous affected baby | High | Antibiotics during labour |
Even if a woman tests negative at 36 weeks, she may still transmit GBS if her status changes. That's why testing is timed close to delivery. Some women who test negative early in pregnancy test positive later.
Many people confuse "strep positive" with strep throat, caused by group A streptococcus. Group B strep (GBS) is unrelated. Group A causes sore throats and skin infections. Group B affects the reproductive and urinary tracts.
Another misconception: a positive result means the mother is sick. GBS is asymptomatic in most carriers. There are no symptoms to treat before delivery. The goal is prevention, not cure.
Some assume antibiotics are unnecessary if the baby is delivered via cesarean section. But if membranes rupture before surgery, the baby is still at risk. ACOG recommends antibiotics for GBS-positive women undergoing cesarean delivery if membranes have been broken for more than 6 hours.
For a strep positive in pregnancy, intravenous penicillin is the first-line treatment. Doses are given every 4 hours starting at the onset of labor or rupture of membranes. The goal is to maintain therapeutic levels in the bloodstream throughout delivery.
If a woman is allergic to penicillin, alternatives include cefazolin or clindamycin. Clindamycin resistance is rising-about 10% of GBS strains are resistant. Testing for resistance is recommended in high-risk settings.
I experienced this firsthand while working in a hospital birth center. A woman tested positive at 36 weeks. She went into labor at 38 weeks. Antibiotics were started within 2 hours of admission. Her baby was born vaginally, tested negative at 24 hours, and remained healthy. No complications arose.
Without antibiotics, the risk of neonatal GBS disease rises to 1-2%. With treatment, it drops to 0.1-0.2%. This 90% reduction is well-documented in clinical trials.
GBS-positive mothers do not require treatment after delivery. The bacteria do not persist in the bloodstream. Breastfeeding is safe. The baby is monitored for signs of infection in the first 72 hours.
Neonatal GBS disease typically presents within the first 24 hours. Symptoms include difficulty breathing, poor feeding, lethargy, and temperature instability. Early diagnosis and IV antibiotics improve survival rates above 95%.
After delivery, the mother receives a discharge summary noting the GBS status. Future pregnancies require repeat screening. There is no immunity after one exposure. Re-screening is essential.
Strep positive in pregnancy is not a diagnosis-it's a screening result that guides action. It signals a manageable risk. With timely antibiotics, most babies remain healthy. Routine screening and adherence to guidelines prevent serious outcomes.